Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
National Health Service
Pharma
NICE to phase rollout for Lilly's tirzepatide in obesity
Roughly 220,000 people in England will be eligible for the drug during the three-year launch phase.
Zoey Becker
Dec 4, 2024 7:01pm
NHS England proposes phased rollout for Lilly's obesity med
Oct 3, 2024 3:22pm
Kate Middleton's cancer reveal sends NHS searches skyrocketing
Mar 27, 2024 12:04pm
UK program will provide patients with Novo's obesity med Wegovy
Jun 7, 2023 11:02am
NICE signs off on AbbVie, J&J's Imbruvica-Venclyxta combo in CLL
Apr 21, 2023 11:30am
UK opens facility to develop and produce cell and gene therapies
Mar 14, 2023 9:50am
